Correlation Between Vitrolife and Biotage AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vitrolife and Biotage AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and Biotage AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and Biotage AB, you can compare the effects of market volatilities on Vitrolife and Biotage AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of Biotage AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and Biotage AB.

Diversification Opportunities for Vitrolife and Biotage AB

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Vitrolife and Biotage is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and Biotage AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotage AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with Biotage AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotage AB has no effect on the direction of Vitrolife i.e., Vitrolife and Biotage AB go up and down completely randomly.

Pair Corralation between Vitrolife and Biotage AB

Assuming the 90 days trading horizon Vitrolife AB is expected to generate 1.24 times more return on investment than Biotage AB. However, Vitrolife is 1.24 times more volatile than Biotage AB. It trades about 0.07 of its potential returns per unit of risk. Biotage AB is currently generating about 0.06 per unit of risk. If you would invest  14,418  in Vitrolife AB on August 26, 2024 and sell it today you would earn a total of  7,722  from holding Vitrolife AB or generate 53.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vitrolife AB  vs.  Biotage AB

 Performance 
       Timeline  
Vitrolife AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vitrolife is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Biotage AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotage AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Vitrolife and Biotage AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vitrolife and Biotage AB

The main advantage of trading using opposite Vitrolife and Biotage AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, Biotage AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotage AB will offset losses from the drop in Biotage AB's long position.
The idea behind Vitrolife AB and Biotage AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals